Literature DB >> 29477784

Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.

L F Yang1, X Liu2, L L Lv3, Z M Ma4, X C Feng5, T H Ma6.   

Abstract

OBJECTIVE: The aim of this study was to investigate the antifungal activity of dracorhodin perchlorate (DP) against planktonic growth and virulence factors of Candida albicans.
METHODS: Microdilution method based on CLSI-M27-A3 was used to test the antifungal susceptibility of DP. The activity of DP against biofilm formation and development of C. albicans was quantified by XTT assay and visualized by confocal laser scanning microscope. The effect of DP on the morphological transition of C. albicans induced by four kinds of hyphal-inducing media at 37°C for 4hours was observed under microscope. The rescue experiment by adding exogenous cAMP analog was performed to investigate the involvement of cAMP in the yeast to hyphal transition and biofilm formation of C. albicans. Egg yolk emulsion agar was used to determine the inhibition of DP on the phospholipase production of C. albicans. Human JEG-3 and HUVEC cell lines, as well as the nematode Caenorhabditis elegans was used to assess the toxicity of DP.
RESULTS: The minimum inhibitory concentration (MIC) of DP is 64μM while the antifungal activity was fungistatic. As low as a concentration at 16μM, DP could inhibit the yeast to hyphal transition in liquid RPMI-1640, Spider, GlcNAc and 10% FBS-containing Sabouroud Dextrose medium, as well as on the solid spider agar. Exogenous cAMP analog could rescue part of biofilm viability of C. albicans. DP could inhibit the production of phospholipase. The toxicity of DP against human cells and C. elegans is low.
CONCLUSION: DP could inhibit the planktonic growth and virulent factors in multiple stages, such as yeast to hyphal transition, adhesion, biofilm formation and production of phospholipase of C. albicans.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antifungal; Biofilm; Candida albicans; Dracorhodin perchlorate; Virulence factor

Mesh:

Substances:

Year:  2018        PMID: 29477784     DOI: 10.1016/j.mycmed.2017.12.011

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  6 in total

1.  In vitro and in vivo Activity of Phibilin Against Candida albicans.

Authors:  Zhongjie Li; Xiaoyuan Jing; Yaping Yuan; Yingbin Shui; Shasha Li; Zhuoran Zhao; Bo Deng; Wenlu Zhang
Journal:  Front Microbiol       Date:  2022-05-11       Impact factor: 6.064

2.  Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.

Authors:  Jhones do Nascimento Dias; Calliandra de Souza Silva; Alyne Rodrigues de Araújo; Jessica Maria Teles Souza; Paulo Henrique de Holanda Veloso Júnior; Wanessa Felix Cabral; Maria da Glória da Silva; Peter Eaton; José Roberto de Souza de Almeida Leite; André Moraes Nicola; Patrícia Albuquerque; Ildinete Silva-Pereira
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

3.  Lycorine Hydrochloride Inhibits the Virulence Traits of Candida albicans.

Authors:  Longfei Yang; Xin Liu; Yujie Sui; Zhiming Ma; Xuechao Feng; Fang Wang; Tonghui Ma
Journal:  Biomed Res Int       Date:  2019-06-03       Impact factor: 3.411

4.  Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms.

Authors:  Mengli Chen; Ting Cheng; Chen Xu; Min Pan; Jiadi Wu; Tianming Wang; Daqiang Wu; Guiming Yan; Changzhong Wang; Jing Shao
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

5.  New N-(oxazolylmethyl)-thiazolidinedione Active against Candida albicans Biofilm: Potential Als Proteins Inhibitors.

Authors:  Gabriel Marc; Cătălin Araniciu; Smaranda Dafina Oniga; Laurian Vlase; Adrian Pîrnău; Mihaela Duma; Luminița Măruțescu; Mariana Carmen Chifiriuc; Ovidiu Oniga
Journal:  Molecules       Date:  2018-10-02       Impact factor: 4.411

6.  Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL-stimulated NFATc1 activity.

Authors:  Yuhao Liu; Ziyi Wang; Chao Ma; Zhenquan Wei; Kai Chen; Chao Wang; Chi Zhou; Leilei Chen; Qingwen Zhang; Zhenqiu Chen; Wei He; Jiake Xu
Journal:  J Cell Mol Med       Date:  2020-01-21       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.